Marion Avril of MalarVx, Inc. joins TWiP to discuss an accelerated prime-and-trap regimen using repRNA-based circumsporozoite vaccine.

In 2023, Dr. Marion Avril, the Principal Scientist and Program Director at MalarVx, presented a poster at the American Society of Tropical Medicine and Hygiene (ASTMH) annual conference. This session highlighted recent advancements in their vaccine research and development efforts aimed at eradicating malaria globally.

MalarVx Inc. participated in the 2022 American Society of Tropical Medicine and Hygiene (ASTMH) international conference.

MalarVx Inc. participated remotely at the virtual 2021 American Society of Tropical Medicine and Hygiene (ASTMH) international conference.